Accupril (Parke-Davis Div of Pfizer Inc)
Welcome to the PulseAid listing for the Accupril drug offered from Parke-Davis Div of Pfizer Inc. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Parke-Davis Div of Pfizer Inc |
| NON-PROPRIETARY NAME: | quinapril hydrochloride |
| SUBSTANCE NAME: | QUINAPRIL HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1991-11-19 |
| END MARKETING DATE: | 0000-00-00 |
Accupril HUMAN PRESCRIPTION DRUG Details:
| Item Description | Accupril from Parke-Davis Div of Pfizer Inc |
| LABELER NAME: | Parke-Davis Div of Pfizer Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/1) |
| START MARKETING DATE: | 1991-11-19 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0071-0527_5bf68301-48f6-4c30-b27e-91e9a74dc5d0 |
| PRODUCT NDC: | 0071-0527 |
| APPLICATION NUMBER: | NDA019885 |
Other QUINAPRIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
